Valuation: Celltrion, Inc.

Market Cap 41,918B 31.29B 27.96B 26.08B 23.69B 44.62B 3,027B 44.96B 313B 122B 1,539B 117B 115B 4,949B P/E 2026 *
27.8x
P/E 2027 * 23.8x
Enterprise Value 44.06B 32.89M 29.39M 27.42M 24.9M 46.9M 3.18B 47.25M 329M 129M 1.62B 123M 121M 5.2B EV / Sales 2026 *
7.89x
EV / Sales 2027 * 6.78x
Free-Float
60.59%
Yield 2026 *
0.41%
Yield 2027 * 0.43%
1 day-0.11%
1 week+1.96%
Current month+2.64%
1 month-3.03%
3 months+3.70%
6 months-2.19%
Current year+5.81%
1 week 178,200
Extreme 178200
186,800
1 month 174,600
Extreme 174600
188,800
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 120,791.91
Extreme 120791.906503
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,047.62
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 20/03/2015
Chief Executive Officer 42 26/03/2021
President 51 13/02/2026
Director TitleAgeSince
Chairman 69 -
Director/Board Member 61 01/04/2005
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
16/1/26 Sell 500 0.0002%
16/1/26 Sell 1,000 0.0004%
16/1/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.11%+1.96%+9.19%+52.66% 31.29B
+4.16%+4.16%+49.37%+94.17% 74.68B
+0.46%-0.97%+23.51%+79.34% 58.7B
+0.17%+0.35%+6.85%+34.55% 48.36B
+0.50%-2.14%+331.33%+702.20% 43.05B
-0.72%-3.99%+28.50%+29.94% 42.48B
+0.34%-0.52%+6.56%+109.35% 41.39B
-0.50%-3.10%-10.19%-14.35% 23.93B
-3.32%-10.86%-37.32%+316.28% 22.22B
+0.20%+6.15%+18.82%+2.05% 22.24B
Average +0.12%-1.35%+42.66%+140.62% 40.83B
Weighted average by Cap. +0.65%-1.14%+50.88%+141.47%

Financials

2026 *2027 *
Net sales 5,586B 4.17B 3.73B 3.48B 3.16B 5.95B 403B 5.99B 41.77B 16.32B 205B 15.65B 15.32B 659B 6,364B 4.75B 4.24B 3.96B 3.6B 6.77B 460B 6.82B 47.59B 18.59B 234B 17.83B 17.45B 751B
Net income 1,538B 1.15B 1.03B 957M 869M 1.64B 111B 1.65B 11.5B 4.49B 56.47B 4.31B 4.22B 182B 1,780B 1.33B 1.19B 1.11B 1.01B 1.89B 129B 1.91B 13.31B 5.2B 65.36B 4.99B 4.88B 210B
Net Debt 2,141B 1.6B 1.43B 1.33B 1.21B 2.28B 155B 2.3B 16.01B 6.26B 78.63B 6B 5.87B 253B 1,251B 934M 834M 779M 707M 1.33B 90.34B 1.34B 9.36B 3.66B 45.95B 3.51B 3.43B 148B
Projected Income Statement - Annual - Celltrion, Inc.
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
07/10/26 ₩183,500.00 +0.60% 254,258
06/10/26 ₩182,400.00 -0.11% 346,310
02/10/26 ₩182,600.00 -0.54% 319,980
01/10/26 ₩183,600.00 +3.32% 422,088
30/09/26 ₩177,700.00 -0.67% 352,051
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Celltrion, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
183,500.00KRW
Average target price
267,741.48KRW
Spread / Average Target
+45.91%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Celltrion, Inc.
  1. Stock Market
  2. Stocks
  3. A068270 Stock